Dr. Camacho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1180 N Indian Canyon Dr
Ste E218
Palm Springs, CA 92262Phone+1 760-416-4880Fax+1 760-416-4875
Education & Training
Memorial Sloan Kettering Cancer CenterImmunology, 1976 - 1979
Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 1973 - 1975
University of Pennsylvania Health SystemInternship, Internal Medicine, 1972 - 1973
Loma Linda University School of MedicineClass of 1972
Certifications & Licensure
CA State Medical License 1973 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Palm Springs Life Magazine Castle Connolly, 2005-2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:San Diego Area Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed Myeloma Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 26 citationsPhase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethason...William I. Bensinger, Sundar Jagannath, Robert Vescio, Elber Camacho, Jeffrey L. Wolf
British Journal of Haematology. 2010-02-01 - 35 citationsExtended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myelomaSundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf, Elber Camacho, David Irwin
British Journal of Haematology. 2009-09-01 - 256 citationsBendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent StudyJonathan W. Friedberg, Philip Cohen, Ling Chen, K. Sue Robinson, Andres Forero-Torres
Journal of Clinical Oncology. 2008-01-10
Press Mentions
PDHS Football Player Never Lost Hope During Battle with Rare Bone CancerJune 21st, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
